Sunitinib Malate 200mg
Sunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST).
| Trivial name | Sunitinib Malate 200mg |
| Catalog Number | A10880-200 |
| Alternative Name(s) | N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate |
| Molecular Formula | C22H27FN4O2.C4H6O5 |
| CAS# | 341031-54-7 |
| SMILES | CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C2/C3=C(C=CC(=C3)F)NC2=O)C.C([C@@H](C(=O)O)O)C(=O)O |
| Size | 200mg |
| Supplier Page | http://www.adooq.com/sunitinib-malate.html |